Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

September 15, 2024; Volume 21,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Chen, Li

    1. Open Access
      Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer
      Xiuzhi Zhu, Xiaohan Ying, Yin Liu, Yunyi Wang, Li Chen, Zhiming Shao, Xi Jin, Yizhou Jiang and Zhonghua Wang
      Cancer Biology & Medicine September 2024, 21 (9) 784-798; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0009
  2. Chen, Xingyun

    1. Open Access
      Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study
      Yuxiao Liu, Xiaofan Guo, Peijun Xu, Yuning Song, Jing Huang, Xingyun Chen, Wenbo Zhu, Jihui Hao and Song Gao
      Cancer Biology & Medicine September 2024, 21 (9) 799-812; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0036
  3. Cheng, Xiangdong

    1. Open Access
      The role of reactive oxygen species in gastric cancer
      Yuqi Wang, Jingli Xu, Zhenjie Fu, Ruolan Zhang, Weiwei Zhu, Qianyu Zhao, Ping Wang, Can Hu and Xiangdong Cheng
      Cancer Biology & Medicine September 2024, 21 (9) 740-753; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0182
  4. Dai, Lei-Jie

    1. Open Access
      Evolving molecular subtyping of breast cancer advances precision treatment
      Rui Shan, Lei-Jie Dai, Zhi-Ming Shao and Yi-Zhou Jiang
      Cancer Biology & Medicine September 2024, 21 (9) 731-739; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0222
  5. Du, Shuya

    1. Open Access
      The current role of dendritic cells in the progression and treatment of colorectal cancer
      Yuanci Zhang, Songtao Ji, Ge Miao, Shuya Du, Haojia Wang, Xiaohua Yang, Ang Li, Yuanyuan Lu, Xin Wang and Xiaodi Zhao
      Cancer Biology & Medicine September 2024, 21 (9) 769-783; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0188
  6. Fu, Zhenjie

    1. Open Access
      The role of reactive oxygen species in gastric cancer
      Yuqi Wang, Jingli Xu, Zhenjie Fu, Ruolan Zhang, Weiwei Zhu, Qianyu Zhao, Ping Wang, Can Hu and Xiangdong Cheng
      Cancer Biology & Medicine September 2024, 21 (9) 740-753; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0182
  7. Gao, Song

    1. Open Access
      Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study
      Yuxiao Liu, Xiaofan Guo, Peijun Xu, Yuning Song, Jing Huang, Xingyun Chen, Wenbo Zhu, Jihui Hao and Song Gao
      Cancer Biology & Medicine September 2024, 21 (9) 799-812; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0036
  8. Guo, Xiaofan

    1. Open Access
      Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study
      Yuxiao Liu, Xiaofan Guo, Peijun Xu, Yuning Song, Jing Huang, Xingyun Chen, Wenbo Zhu, Jihui Hao and Song Gao
      Cancer Biology & Medicine September 2024, 21 (9) 799-812; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0036
  9. Han, Jiaxin

    1. Open Access
      Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma
      Jiaxin Han, Wentao Kuai, Liu Yang, Xuemei Tao, Yuekui Wang, Minghui Zeng, Yuqin Li, Yuqiang Mi, Ningning Zhang, Wei Lu and Liang Xu
      Cancer Biology & Medicine September 2024, 21 (9) 813-825; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0048
  10. Hao, Jihui

    1. Open Access
      Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study
      Yuxiao Liu, Xiaofan Guo, Peijun Xu, Yuning Song, Jing Huang, Xingyun Chen, Wenbo Zhu, Jihui Hao and Song Gao
      Cancer Biology & Medicine September 2024, 21 (9) 799-812; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0036
« Previous (Pages : 1 2 3 4 5 6 ... 6) Next »
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 21 (9)
Cancer Biology & Medicine
Vol. 21, Issue 9
15 Sep 2024
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire